Ottobock acquires Blatchford Norway in €110M European expansion
Ottobock SE & Co. KGaA is set to acquire Blatchford Norway A/S, the Norwegian patient care division of Blatchford Ltd. The deal, valued at around €110 million, will expand Ottobock’s presence in a key European market.
The transaction is expected to complete within days, adding eight new care locations to Ottobock’s network. Blatchford Norway A/S is a leading provider of prosthetics and orthotics in Norway. With roughly 200 employees and eight clinics, the company generates annual revenues of about €40 million. Blatchford Ltd. forecasts continued growth, with high single-digit revenue increases expected in the coming years.
Ottobock’s acquisition follows its earlier integration of local market leaders like Sahva A/S, Livit B.V., and Vigo. The move aligns with the company’s strategy to strengthen its patient care network across Europe. Paul Roberts, CEO of Blatchford, highlighted that the deal combines local expertise with the global scale of Ottobock, securing a strong future for Norwegian patients and staff. The takeover will bring Blatchford Norway’s operations under Ottobock’s management. The expanded network will offer more patients access to advanced prosthetics and orthotics services. Finalisation of the deal is anticipated in the next few days.
Read also:
- Federal Funding Supports Increase in Family Medicine Residency Program, Focusing on Rural Health Developments
- Potential Role of DHA in Shielding the Brain from Saturated Fats?
- Alternative Gentle Retinoid: Exploring Bakuchiol Salicylate for Sensitive Skin
- Hanoi initiates a trial program for rabies control, along with efforts to facilitate the transition from the dog and cat meat trade industry.
